Two Sigma Securities
TEVA icon

Two Sigma Securities’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Two Sigma Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Buy
+6,797
New +$226K 0.02% 1073
2024
Q3 		– Sell
-16,253
Closed -$284K – 3618
2024
Q2 		$264K Buy
+16,253
New +$250K ﹤0.01% 2110
2023
Q3 		– Sell
-15,494
Closed -$117K – 3468
2023
Q2 		$117K Sell
15,494
-77,963
-83% -$632K ﹤0.01% 2306
2023
Q1 		$827K Sell
93,457
-14,005
-13% -$138K 0.02% 940
2022
Q4 		$980K Buy
+107,462
New +$938K 0.03% 698
2022
Q3 		– Sell
-127,020
Closed -$1.12M – 3085
2022
Q2 		$955K Buy
127,020
+94,471
+290% +$823K 0.03% 553
2022
Q1 		$306K Buy
32,549
+19,978
+159% +$167K 0.01% 1389
2021
Q4 		$101K Sell
12,571
-41,574
-77% -$375K ﹤0.01% 1181
2021
Q3 		$527K Sell
54,145
-9,095
-14% -$85.2K 0.02% 747
2021
Q2 		$626K Buy
+63,240
New +$669K 0.02% 561
2020
Q4 		– Sell
-12,972
Closed -$124K – 1942
2020
Q3 		$117K Buy
12,972
+800
+7% +$8.46K ﹤0.01% 1168
2020
Q2 		$150K Sell
12,172
-3,837
-24% -$43.4K ﹤0.01% 1182
2020
Q1 		$144K Buy
16,009
+2,712
+20% +$27.8K ﹤0.01% 1103
2019
Q4 		$130K Buy
+13,297
New +$119K ﹤0.01% 2177
2019
Q3 		– Sell
-15,274
Closed -$141K – 2451
2019
Q2 		$141K Sell
15,274
-73,480
-83% -$886K ﹤0.01% 1802
2019
Q1 		$1.39M Buy
88,754
+72,071
+432% +$1.27M 0.01% 442
2018
Q4 		$257K Sell
16,683
-31,338
-65% -$642K ﹤0.01% 1512
2018
Q3 		$1.03M Buy
48,021
+37,062
+338% +$860K 0.01% 1014
2018
Q2 		$267K Sell
10,959
-53,590
-83% -$1.09M ﹤0.01% 2145
2018
Q1 		$1.1M Buy
64,549
+6,565
+11% +$128K 0.01% 1199
2017
Q4 		$1.1M Buy
+57,984
New +$872K 0.03% 399
2017
Q2 		– Sell
-16,595
Closed -$533K – 1173
2017
Q1 		$533K Sell
16,595
-10,388
-38% -$355K 0.1% 182
2016
Q4 		$978K Sell
26,983
-28,113
-51% -$1.12M 0.33% 57
2016
Q3 		$2.54M Buy
55,096
+48,111
+689% +$2.51M 0.86% 12
2016
Q2 		$351K Buy
6,985
+3,163
+83% +$168K 0.19% 153
2016
Q1 		$205K Buy
+3,822
New +$224K 0.26% 134

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Two Sigma Securities's TEVA Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 6,797 shares worth $230K. The stake represents 0.02% of the portfolio and ranks #1073 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in TEVA as recently as Q2 2024.

Two Sigma Securities first reported a position in TEVA in Q1 2016 and has held it in 26 quarters since. The position peaked at $2.54M in Q3 2016. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Two Sigma Securities held 6,797 shares of Teva Pharmaceutical Industries Limited worth $230K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Two Sigma Securities position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1073 holding.
  • Two Sigma Securities first reported a position in Teva Pharmaceutical Industries Limited in Q1 2016 and has held it in 26 quarters since.
  • Two Sigma Securities's Teva Pharmaceutical Industries Limited position peaked at $2.54M in Q3 2016.
  • 677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.